Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials

by Kotecki, Nuria, Penel, Nicolas, Adenis, Antoine, Ferte, Charles, Clisant, Stéphanie
Published 2012

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome

by Adenis, Antoine, Tresch, Emmanuelle, Dewas, Sylvain, Romano, Olivier, Messager, Mathieu, Amela, Eric, Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Mirabel, Xavier
Published 2013

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study

by Ligier, Karine, Maynou, Carlos, Leroy, Xavier, Robin, Yves-Marie, Martin, Philippe, Clisant, Stéphanie, Richard, Florence, Penel, Nicolas
Published 2015

Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA)

by Christophe, Véronique, Leroy, Tanguy, Seillier, Mélanie, Duthilleul, Camille, Julieron, Morbize, Clisant, Stéphanie, Foncel, Jérôme, Vallet, Fanny, Lefebvre, Jean-Louis
Published 2014

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

by Diane Pannier, Antoine Adenis, Emilie Bogart, Eric Dansin, Stéphanie Clisant-Delaine, Emilie Decoupigny, Anne Lesoin, Eric Amela, Sandrine Ducornet, Jean-Pierre Meurant, Marie-Cécile Le Deley, Nicolas Penel
Published 2018-07-01

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

by Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
Published 2015

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

by Adenis, A, Ray-Coquard, I, Italiano, A, Chauzit, E, Bui-Nguyen, B, Blay, J-Y, Tresch-Bruneel, E, Fournier, C, Clisant, S, Amela, E Y, Cassier, P A, Molimard, M, Penel, N
Published 2013

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

by Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Published 2016

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)†

by Bompas, E., Le Cesne, A., Tresch-Bruneel, E., Lebellec, L., Laurence, V., Collard, O., Saada-Bouzid, E., Isambert, N., Blay, J. Y., Amela, E. Y., Salas, S., Chevreau, C., Bertucci, F., Italiano, A., Clisant, S., Penel, N.
Published 2015

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

by Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Published 2016

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, ra...

by Messager, Mathieu, Mirabel, Xavier, Tresch, Emmanuelle, Paumier, Amaury, Vendrely, Véronique, Dahan, Laetitia, Glehen, Olivier, Vasseur, Frederique, Lacornerie, Thomas, Piessen, Guillaume, El Hajbi, Farid, Robb, William B., Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Adenis, Antoine
Published 2016